Muzzle pharma, harm patients: The dangers of anti-industry bias

Video

Event Summary
The pervasive distrust of the pharmaceutical industry among academics, regulators and medical practitioners could adversely affect patients' health. At an AEI event on Thursday evening, a panel of health experts discussed their research on the unintended consequences of anti-industry bias.

George Chressanthis of Temple University began with an explanation of his recently published paper on the effect of restricting pharmaceutical representatives' access to doctors. His research demonstrates that physicians with limited access to representatives react slower to new medical information, taking longer to begin prescribing breakthrough drugs and to stop prescribing medications with recently discovered dangerous side effects. 

ZS Associates' Nitin Jain (a co-author of Chressanthis's paper) elaborated that their results were significant even after controlling for other factors such as practice size or managed care that might affect access to pharmaceutical representatives. Tom Stossel of Harvard University Medical School then discussed his findings detailing prejudice towards the pharmaceutical industry. In a paper published in April, Stossel found that high-tier medical journals overemphasize the risk of collaboration between industry, practice and academia without mentioning the benefits that can arise from this collaboration. The bias Stossel describes is at the root of the movement to restrict representatives' access to prescribers, a movement which — as Chressanthis and Jain explained — may harm the patients it aims to protect.
-- Catherine Griffin

Event Description
Nearly every week brings both good and bad news about the safety and effectiveness of pharmaceutical products. A timely and clinically relevant way to disseminate this news to physicians and other prescribers is via field and sales communications by pharmaceutical and biotechnology companies. But a growing anti-industry bias — held by academic researchers, health insurers, regulators and others who seek to constrain spending on new medicines — is determined to restrict access to prescribers.

This session will present important new findings on the dangers of blocking pharmaceutical company communications to prescribers. Among the negative effects are continued use of medications despite new safety warnings and slower uptake of breakthrough, potentially life-saving new medicines.

The event will be followed by a wine and cheese reception honoring the late Jack Calfee of AEI, who was excited about this research before his untimely passing.

Full video will be posted within 24 hours.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

J.D.
Kleinke
  • J. D. Kleinke, an expert on health care business strategy and entrepreneurship, was instrumental in the creation of four health care information organizations. He has also advised established and start-up companies on health care business, product and technology strategy. Mr. Kleinke writes on the business of health care, health insurance and benefits as well as about doctors and the culture of medicine. His books include Bleeding Edge: The Business of Health Care in the New Century (Jones & Bartlett Learning, 1998), Oxymorons: The Myth of a U.S. Health Care System (Jossey-Bass, 2001), and Catching Babies (Fourth Chapter Books, 2011). At AEI, he is studying the interplay between health policy, health care market dynamics and health venture formation; the influence of information technology and medical technology on the overall health economy; and the impact of medical culture on health care organizations, markets and public health.

  • Phone: 202 862 5846
    Email: jd.kleinke@aei.org
  • Assistant Info

    Name: Catherine Griffin
    Phone: 202 862 5920
    Email: catherine.griffin@aei.org

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.